Association between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han population

Diabetes Research and Clinical Practice

Volumn 91, Issue 2, 2011, Pages 171-176

  Qu, Lili ^a   He, Bangshun ^a   Pan, Yuqin ^a   Xu, Yongfei ^a   Zhu, Chan ^a   Tang, Zhipeng ^a   Bao, Qian ^a   Tian, Fuliang ^a   Wang, Shukui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

NRF1; Polymorphism; RAPGEF1; TP53; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NRF1 GENE; RAPGEF1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TP53 GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MALE; MIDDLE AGED; NUCLEAR RESPIRATORY FACTOR 1; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952039609     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.11.019     Document Type: Article

References (30)

1. King H., Aubert R.E., Herman W.H. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. Diab Care 1998, 21:1414-1431.
2. Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diab Care 2006, 29:1263-1268.
3. Poulsen P., Kyvik K.O., Vaag A., Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 1999, 42:139-145.
4. Botstein D., Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003, suppl. 33:228-237.
5. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
6. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
7. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
8. Frayling T.M. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 2007, 8:657-662.
9. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
10. Doria A., Patti M.E., Kahn C.R. The emerging genetic architecture of type 2 diabetes. Cell Metab 2008, 8:186-200.
11. Gaulton K.J., Willer C.J., Li Y., Scott L.J., Conneely K.N., Jackson A.U., et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 2008, 57:3136-3144.
12. Hong K.W., Jin H.S., Lim J.E., Ryu H.J., Go M.J., Lee J.Y., et al. RAPGEF1 gene variants associated with type 2 diabetes in the Korean population. Diab Res Clin Pract 2009, 84:117-122.
13. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998, 15:539-553.
14. Naccarati A., Pardini B., Polakova V., Smerhovsky Z., Vodickova L., Soucek P., et al. Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. Carcinogenesis 2010, 31:666-670.
15. Do T.N., Ucisik-Akkaya E., Davis C.F., Morrison B.A., Dorak M.T. TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility. Cancer Genet Cytogenet 2009, 195:31-36.
16. Polakova V., Pardini B., Naccarati A., Landi S., Slyskova J., Novotny J., et al. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum Mutat 2009, 30:661-668.
17. Prokocimer M., Unger R., Rennert H.S., Rotter V., Rennert G. Pooled analysis of p53 mutations in hematological malignancies. Hum Mutat 1998, 12:4-18.
18. Spitsina E.V., Iakunina N., Chudakova D.A., Nikitin A.G., Svetlova G.N., Soluianova T.N., et al. Association of polymorphous markers Pro72Arg and C(-594) CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow. Mol Biol (Mosk) 2007, 41:989-993.
19. Marchenko N.D., Zaika A., Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 2000, 275:16202-16212.
20. Dumont P., Leu J.I., Della Pietra A.C., George D.L., Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003, 33:357-365.
21. Baumann C.A., Ribon V., Kanzaki M., Thurmond D.C., Mora S., Shigematsu S., et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407:202-207.
22. Chiang S.H., Baumann C.A., Kanzaki M., Thurmond D.C., Watson R.T., Neudauer C.L., et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001, 410:944-948.
23. Cheng L.S., Davis R.C., Raffel L.J., Xiang A.H., Wang N., Quinones M., et al. Coincident linkage of fasting plasma insulin and blood pressure to chromosome 7q in hypertensive hispanic families. Circulation 2001, 104:1255-1260.
24. Baar K., Song Z., Semenkovich C.F., Jones T.E., Han D.H., Nolte L.A., et al. Skeletal muscle overexpression of nuclear respiratory factor 1 increases glucose transport capacity. FASEB J 2003, 17:1666-1673.
25. Elbein S.C. Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology 2002, 143:2012-2018.
26. Gloyn A.L., McCarthy M.I. The genetics of type 2 diabetes. Best Pract Res Clin Endocrinol Metab 2001, 15:293-308.
27. Culverhouse R., Suarez B.K., Lin J., Reich T. A perspective on epistasis: limits of models displaying no main effect. Am J Hum Genet 2002, 70:461-471.
28. Hanlon P., Lorenz W.A., Shao Z., Harper J.M., Galecki A.T., Miller R.A., et al. Three-locus and four-locus QTL interactions influence mouse insulin-like growth factor-I. Physiol Genomics 2006, 26:46-54.
29. Jarvis J.P., Cheverud J.M. Epistasis and the evolutionary dynamics of measured genotypic values during simulated serial bottlenecks. J Evol Biol 2009, 22:1658-1668.
30. Franke L., van Bakel H., Fokkens L., de Jong E.D., Egmont-Petersen M., Wijmenga C. Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am J Hum Genet 2006, 78:1011-1025.